Assistant Editor: Special
Assignments
JULIA AALBERS
TEL: (021) 976-4378
FAX: 086 610 3395
e-mail:
Production Editor
SHAUNA GERMISHUIZEN
TEL: (021) 785-7178
FAX: 086 628 1197
e-mail:
Editorial Assistant and
Circulation
ELSABÉ BURMEISTER
TEL/FAX: (021) 976-8129
e-mail:
Production Co-ordinator
WENDY WEGENER
TEL: (021) 976-4378
e-mail:
The
South African Journal of
Diabetes and Vascular Disease
is
published four times a year for
Clinics-Cardive Publishing Co.
by Martingraphix and printed
by Durbanville Commercial
Printers. Articles in this Journal
are sourced as per agreement
with the British Journal of
Diabetes and
Vascular Disease
All correspondence to be directed
to:
THE EDITOR
PO BOX 1013
DURBANVILLE
7551
or
TEL/FAX: (021) 976-8129
INT: 2721 976-8129
The opinions, data and statements
that appear in any articles pub-
lished in this journal are those of
the contributors. The publisher, edi-
tors and members of the editorial
board do not necessarily share the
views expressed herein. Although
every effort is made to ensure
accuracy and avoid mistakes, no
liability on the part of the publisher,
editors, the editorial board or their
agents or employees is accepted
for the consequences of any inac-
curate or misleading information.
African Focus
156
African Diabetes Leadership Forum calls for activism around
non-communicable diseases
WF Mollentze, JMM Koning, P Wagenaar
Achieving Best Practice
160
Incretin mimetics: where will they make a difference?
A Kok
Diabetes Personalities
165
Making a difference among disadvantaged diabetic children in the
southern Cape
EASD Watch
167
2010 update from Stockholm
W de Lange, G Hough
You and Your Patient
173
Diabetes, insulin and cancer risk
Interview with Dr A Liebl
Journal Update
174
Focus on neuropathy
J Aalbers
Drug Trends in Diabetes
131
Once-daily duloxetine reduces pain symptoms over and above
antidepressant action
JL Aalbers
Lilly supports development of
diabetes youth leaders
Front cover photographs:
• Left and right – Healthy feet are an
important focus for primary care of
the diabetic patient and preventing
complications of peripheral neuropathy.
• Centre – Managing blood pressure as a
cardiovascular risk factor is important in
diabetes control and well-being.
It's the
shell that
makes
safer.
R
Safety-Coated
R
81mg
The ORIGINAL low dose aspirin
for optimum cardio-protection
Hp
Each tablet contains Aspirin 81mg. Reg.No.: 29/2.7/0767
Pharmafrica (Pty) Ltd, 33 Hulbert Road, New Centre, Johannesburg 2001
Under licence from Goldshield Pharmaceuticals Ltd. U.K.
55X78MM
23 September 2008 10:04:25 AM
Color profile: Generic CMYK printer profile
Composite Default screen
